BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27166996)

  • 21. Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer.
    Liu Y; Zhang X; Zhang Y; Hu Z; Yang D; Wang C; Guo M; Cai Q
    Cancer Lett; 2015 Dec; 369(1):58-66. PubMed ID: 26276722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic silencing of miRNA-9 is correlated with promoter-proximal CpG island hypermethylation in gastric cancer in vitro and in vivo.
    Li Y; Xu Z; Li B; Zhang Z; Luo H; Wang Y; Lu Z; Wu X
    Int J Oncol; 2014 Dec; 45(6):2576-86. PubMed ID: 25270964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-122-5p suppresses the proliferation, migration, and invasion of gastric cancer cells by targeting LYN.
    Meng L; Chen Z; Jiang Z; Huang T; Hu J; Luo P; Zhang H; Huang M; Huang L; Chen Y; Lu M; Xu AM; Ying S
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):49-57. PubMed ID: 31828293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.
    Luo H; Yang R; Li C; Tong Y; Fan L; Liu X; Xu C
    Tumour Biol; 2017 Jul; 39(7):1010428317718414. PubMed ID: 28720065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
    Zeng B; Shi W; Tan G
    BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.
    Eun JW; Kim HS; Shen Q; Yang HD; Kim SY; Yoon JH; Park WS; Lee JY; Nam SW
    J Pathol; 2018 Jan; 244(1):107-119. PubMed ID: 28991363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
    Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
    Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.
    Zhou Y; Huang T; Zhang J; Wong CC; Zhang B; Dong Y; Wu F; Tong JHM; Wu WKK; Cheng ASL; Yu J; Kang W; To KF
    Oncogene; 2017 Nov; 36(47):6518-6530. PubMed ID: 28759040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth.
    Li Z; Yu X; Wang Y; Shen J; Wu WK; Liang J; Feng F
    Oncotarget; 2015 Jul; 6(19):17559-69. PubMed ID: 25654811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consistency analysis of microRNA-arm expression reveals microRNA-369-5p/3p as tumor suppressors in gastric cancer.
    Dong L; Zhang Z; Xu J; Wang F; Ma Y; Li F; Shen C; Liu Z; Zhang J; Liu C; Yi P; Yu J
    Mol Oncol; 2019 Jul; 13(7):1605-1620. PubMed ID: 31162777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer.
    Hashimoto Y; Akiyama Y; Yuasa Y
    PLoS One; 2013; 8(5):e62589. PubMed ID: 23667495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of aberrantly expressed SERPINH1 by antitumor miR-148a-5p inhibits cancer cell aggressiveness in gastric cancer.
    Kawagoe K; Wada M; Idichi T; Okada R; Yamada Y; Moriya S; Okubo K; Matsushita D; Arigami T; Kurahara H; Maemura K; Natsugoe S; Seki N
    J Hum Genet; 2020 Aug; 65(8):647-656. PubMed ID: 32235846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells.
    Xu M; Bian S; Li J; He J; Chen H; Ge L; Jiao Z; Zhang Y; Peng W; Du F; Mo Y; Gong A
    Oncotarget; 2016 Mar; 7(12):14476-85. PubMed ID: 26910839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway.
    Li L; Zhao J; Huang S; Wang Y; Zhu L; Cao Y; Xiong J; Deng J
    Gene; 2018 Jan; 641():240-247. PubMed ID: 29045821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulating microRNA-498 inhibits gastric cancer proliferation invasion and chemoresistance through inverse interaction of Bmi1.
    Zhao T; Chen Y; Sheng S; Wu Y; Zhang T
    Cancer Gene Ther; 2019 Nov; 26(11-12):366-373. PubMed ID: 30518783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/MEK1/ERK1/2 signaling.
    Zhang J; Hou L; Liang R; Chen X; Zhang R; Chen W; Zhu J
    Mol Cancer; 2019 Apr; 18(1):80. PubMed ID: 30953514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-302b-3p Suppresses Cell Proliferation Through AKT Pathway by Targeting IGF-1R in Human Gastric Cancer.
    Guo B; Zhao Z; Wang Z; Li Q; Wang X; Wang W; Song T; Huang C
    Cell Physiol Biochem; 2017; 42(4):1701-1711. PubMed ID: 28743112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mecp2-mediated Epigenetic Silencing of miR-137 Contributes to Colorectal Adenoma-Carcinoma Sequence and Tumor Progression via Relieving the Suppression of c-Met.
    Chen T; Cai SL; Li J; Qi ZP; Li XQ; Ye LC; Xie XF; Hou YY; Yao LQ; Xu MD; Zhou PH; Xu JM; Zhong YS
    Sci Rep; 2017 Mar; 7():44543. PubMed ID: 28291253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.